ANGEL LUIS
GUERRERO PERAL
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Hospital Universitario Virgen Macarena
Sevilla, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Virgen Macarena (11)
2024
-
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Frontiers in Neurology , Vol. 15
-
Observational Retrospective Study in Patients Treated with Galcanezumab as Preventive Treatment for Migraine: The ORYGAM Study
Pain and Therapy, Vol. 13, Núm. 3, pp. 557-576
2023
-
Recomendaciones de consenso para el tratamiento de la prevención de la migraña
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 246-253
-
[Translated article] Consensus recommendations on the preventive treatment of migraine
Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. T246-T253
2022
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
2020
-
Evaluation of the concomitant use of oral preventive treatments and onabotulinumtoxinA in chronic migraine: the PREVENBOX study
European Journal of Neurology, Vol. 27, Núm. 10, pp. 2102-2108
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578
2019
-
Epicrania Fugax as the presenting symptom of a cerebellar abscess
Cephalalgia, Vol. 39, Núm. 9, pp. 1200-1203
-
Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice
Neurologia, Vol. 34, Núm. 6, pp. 408-417
-
Real world preventative drug management of migraine among Spanish neurologists
Journal of Headache and Pain, Vol. 20, Núm. 1
2018
-
Patterns of anaesthetic pericranial nerve block in headache patients
Neurologia, Vol. 33, Núm. 3, pp. 160-164